in Taiwanese patients with breast cancer identified PIK3CA as one of the most frequently mutated genes in 38% of the study population, followed by ERBB2 (23%), ESR1 (10%), AKT1 (6%), and BRCA2 (5%) mutations (12). This evidence concerns the gene AKT1 and breast carcinoma.